These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 6177396)
1. Augmentation of the intracellular levels of polyglutamyl derivatives of methotrexate by vincristine and probenecid in Ehrlich ascites tumor cells. Fry DW; Yalowich JC; Goldman ID Cancer Res; 1982 Jul; 42(7):2532-6. PubMed ID: 6177396 [TBL] [Abstract][Full Text] [Related]
2. Characteristics of the accumulation of methotrexate polyglutamate derivatives in Ehrlich ascites tumor cells and isolated rat hepatocytes. Fry DW; Gewirtz DA; Yalowich JC; Goldman ID Adv Exp Med Biol; 1983; 163():215-34. PubMed ID: 6193686 [TBL] [Abstract][Full Text] [Related]
3. Enhanced polyglutamylation of aminopterin relative to methotrexate in the Ehrlich ascites tumor cell in vitro. Matherly LH; Voss MK; Anderson LA; Fry DW; Goldman ID Cancer Res; 1985 Mar; 45(3):1073-8. PubMed ID: 2578870 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and retention of methotrexate polyglutamates in Ehrlich ascites carcinoma cells. Balińska M Drugs Exp Clin Res; 1986; 12(6-7):551-4. PubMed ID: 2427298 [TBL] [Abstract][Full Text] [Related]
5. Differential synthesis of methotrexate polyglutamates in normal proliferative and neoplastic mouse tissues in vivo. Poser RG; Sirotnak FM; Chello PL Cancer Res; 1981 Nov; 41(11 Pt 1):4441-6. PubMed ID: 6171339 [TBL] [Abstract][Full Text] [Related]
6. Role of methotrexate polyglutamylation and cellular energy metabolism in inhibition of methotrexate binding to dihydrofolate reductase by 5-formyltetrahydrofolate in Ehrlich ascites tumor cells in vitro. Matherly LH; Fry DW; Goldman ID Cancer Res; 1983 Jun; 43(6):2694-9. PubMed ID: 6189586 [TBL] [Abstract][Full Text] [Related]
7. Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase. Jolivet J; Chabner BA J Clin Invest; 1983 Sep; 72(3):773-8. PubMed ID: 6193143 [TBL] [Abstract][Full Text] [Related]
8. Studies on the in vivo synthesis of methotrexate polyglutamates and their efflux properties in normal, proliferative, and neoplastic mouse tissues. Poser RG; Sirotnak FM Adv Exp Med Biol; 1983; 163():259-74. PubMed ID: 6193689 [TBL] [Abstract][Full Text] [Related]
9. Exchangeable intracellular methotrexate levels in the presence and absence of vincristine at extracellular drug concentrations relevant to those achieved in high-dose methotrexate-folinic acid "rescue" protocols. Goldman ID; Gupta V; White JC; Loftfield S Cancer Res; 1976 Jan; 36(1):276-9. PubMed ID: 1248006 [TBL] [Abstract][Full Text] [Related]
10. Teniposide (VM-26)- and etoposide (VP-16-213)-induced augmentation of methotrexate transport and polyglutamylation in Ehrlich ascites tumor cells in vitro. Yalowich JC; Fry DW; Goldman ID Cancer Res; 1982 Sep; 42(9):3648-53. PubMed ID: 6179605 [No Abstract] [Full Text] [Related]
11. Regulation of methotrexate polyglutaminate formation in Ehrlich ascites carcinoma cells by endogenous folate pool. Balińska M Acta Biochim Pol; 1986; 33(1):31-7. PubMed ID: 2424199 [TBL] [Abstract][Full Text] [Related]
12. In vitro formation of polyglutamyl derivatives of methotrexate and 7-hydroxymethotrexate in human lymphoblastic leukemia cells. Fabre G; Matherly LH; Favre R; Catalin J; Cano JP Cancer Res; 1983 Oct; 43(10):4648-52. PubMed ID: 6192907 [TBL] [Abstract][Full Text] [Related]
13. Formation of 7-hydroxymethotrexate polyglutamyl derivatives and their cytotoxicity in human chronic myelogenous leukemia cells, in vitro. Fabre G; Goldman ID Cancer Res; 1985 Jan; 45(1):80-5. PubMed ID: 2578101 [TBL] [Abstract][Full Text] [Related]
14. Role of methotrexate polyglutamates in methotrexate- and sequential methotrexate-5-fluorouracil-mediated cell kill. McGuire JJ; Mini E; Hsieh P; Bertino JR Cancer Res; 1985 Dec; 45(12 Pt 1):6395-400. PubMed ID: 2415244 [TBL] [Abstract][Full Text] [Related]
15. Proliferation-dependent cytotoxicity of methotrexate in murine L5178Y leukemia. Fernandes DJ; Sur P; Kute TE; Capizzi RL Cancer Res; 1988 Oct; 48(20):5638-44. PubMed ID: 2458828 [TBL] [Abstract][Full Text] [Related]
16. Polyglutamylation, an important element in methotrexate cytotoxicity and selectivity in tumor versus murine granulocytic progenitor cells in vitro. Fabre I; Fabre G; Goldman ID Cancer Res; 1984 Aug; 44(8):3190-5. PubMed ID: 6204743 [TBL] [Abstract][Full Text] [Related]
17. Prevention of methotrexate cytotoxicity by asparaginase inhibition of methotrexate polyglutamate formation. Jolivet J; Cole DE; Holcenberg JS; Poplack DG Cancer Res; 1985 Jan; 45(1):217-20. PubMed ID: 2578094 [TBL] [Abstract][Full Text] [Related]
18. Formation of methotrexate polyglutamates in rat hepatocytes. Gewirtz DA; White JC; Randolph JK; Goldman ID Cancer Res; 1979 Aug; 39(8):2914-8. PubMed ID: 455278 [TBL] [Abstract][Full Text] [Related]
19. Serum protein reduction of the enhancement of methotrexate accumulation by vincristine and 4'-demethylepipodophyllotoxin in the Ehrlich ascites tumor cell in vitro. Gewirtz DA Cancer Res; 1985 Dec; 45(12 Pt 1):6290-2. PubMed ID: 4063980 [TBL] [Abstract][Full Text] [Related]
20. Intrinsic resistance of cervical squamous cell carcinoma cell lines to methotrexate (MTX) as a result of decreased accumulation of intracellular MTX polyglutamates. Barakat RR; Li WW; Lovelace C; Bertino JR Gynecol Oncol; 1993 Oct; 51(1):54-60. PubMed ID: 7694891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]